Presentation ACC 2024 Primary Results from the Phase 2 KARDIA-2 Study Presenter: Akshay Desai April 07, 2024
News Daily News Antihypertensives Linked to Lower Long-term Dementia Risk Caitlin E. Cox April 01, 2024
News Conference News ACC 2024 ADHD Meds Linked to Cardiomyopathy in Young Adults Todd Neale April 01, 2024
News Daily News Biologic Winrevair Wins FDA Approval for Treatment of PAH L.A. McKeown March 27, 2024
News Conference News Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality Michael O'Riordan March 22, 2024
News Daily News Peer Coaching May Help With BP Control in Rural Black Populations Todd Neale March 22, 2024
News Daily News FDA Approves Aprocitentan for Inadequately Controlled Hypertension Michael O'Riordan March 20, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Daily News Patients With CKD Remain Underrepresented in Trials of CV Meds Todd Neale March 08, 2024
News Daily News One in Three Overweight MI Patients May Benefit From Semaglutide Todd Neale February 26, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News Top General Cardiology and CVD Prevention News of 2023 Yael L. Maxwell January 03, 2024
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds Todd Neale December 06, 2023
News Daily News ‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults Michael O'Riordan November 21, 2023